Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2094)	4/28/2004 5:13:54 PM
From: Icebrg	Read Replies (2) of 3044

MLNM Q1 report To me a disappointment was that the only thing that they felt worth mentioning with regard to their pipeline was: Clinical Highlights In March 2004, Millennium announced that the U.S. Food and Drug Administration selected the Company's investigational cancer therapy MLN2704 for inclusion in the Continuous Marketing Application Pilot 2 Program. Participation in the Pilot 2 Program is limited to no more than one fast track product for each review division within the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research. It seems pretty empty over there. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next